Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness

Main|Search|PHGKB

From From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.  
  Berger Barry M et al. Clinical colorectal cancer 2016 Sep 15(3) e65-74
• Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration.  
  Visser Annemiek et al. PloS one 2017 12(6) e0178205
• A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification.  
  Tognetto Alessia et al. Frontiers in public health 2017 5243
• RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres.  
  Boleij Annemarie et al. BMC cancer 2016 Oct 16(1) 825
• RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.  
  Normanno N et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Aug

more